All episodes

Emerging Agents In Small Cell Lung Cancer

Radiopharmaceuticals and Lung Cancer

FDA Approval: 1L Amivantamab plus Chemotherapy for EGFR Exon 20 NSCLC

Seminal Trials: Nivolumab Phase I Trial & Immunotherapy for NSCLC

From the Basics to Next Line Therapy: ALK + NSCLC

Best Practice for RET NSCLC

Biomarkers in Lung Cancer: Barriers to Implementation

LCC in Cantonese Chinese: Barriers to Biomarker Testing

LCC in Mandarin Chinese: Barriers to Biomarker Testing

LCC in French Canadian: Barriers to Biomarker Testing

LCC in Portuguese: Barriers to Biomarker Testing

LCC in French: Barriers to Biomarker Testing

LCC in Japanese: Barriers to Biomarker Testing

LCC in Spanish: Barriers to Biomarker Testing

The IASLC’s 50th Anniversary and New Strategic Plan

LCC in Cantonese: Biomarker Testing and EGFR Mutant NSCLC

Meet the New IASLC Chief Scientific Officer Dr. Jennifer King

Lung Cancer in MENA: Clinical and Research Initiatives

IASLC - Oligometastatic Lung Cancer Part 2

Lung Cancer Considered: A Three-Year Review

IASLC Oligometastatic NSCLC

Maximizing Supportive Care in Lung Cancer

Lung Cancer in MENA: Clinical and Research Initiatives

IASLC Chronic Toxicity From Targeted Therapy

LCC in Korean: Managing EGFR+ NSCLC

New Options for Initial Treatment of EGFR Mutant NSCLC

Research from NACLC: Nutrition as Medicine and Lung Cancer Screening

FDA Approval: Repotrectinib, a ROS1 and NTRK inhibitor

FDA Approval: Perioperative Pembrolizumab and KEYNOTE 671

It's time to talk about sexual health and lung cancer!

Virtual Tumor Board: Neoadjuvant for Stage III NSCLC

LCC in Dutch: Lung Cancer Care in The Netherlands

AEGEAN and Beyond: Perioperative Immunotherapy for NSCLC

Updated IASLC - Hindi

FDA Approval: Encorafenib + Binimetinib in BRAF V600E NSCLC

ESMO 2023 Highlights: Early Stage NSCLC, SCLC, Thymic Carcinoma

ESMO 2023 Highlights: Metastatic NSCLC

Lung Cancer Care and Research in Japanese

Lung Cancer Considered--Hungarian Episode

IASLC - Mesothelioma

NACLC 2023 Preview

WCLC 2023 - Meeting Wrap Up

WCLC 2023 - Tuesday Highlights

MARS 2 in Spanish--Monday WCLC Highlights

Live from WCLC: Monday Highlights

Live from WCLC: Sunday Highlights

Title: Gender Equity and Beyond, a discussion with HRH Princess Dina Mired of Jordan

IASLC Lung Cancer Considered Drug Development and Targeted Therapies

I want to be an oncologist: Where to start?

Lung Cancer Care in Mandarin: EGFR in China - From Testing to Treating

Artificial Intelligence And Lung Cancer

LCC in Greek: Treating Lung Cancer in Greece

IASLC Hot Topic in Basic and Translational Science Meeting Preview

Updated IASLC - Virtual Tumor Board On SCLC

iMig Meeting Highlights

IASLC - EGFR NSCLC In Brazil

Evolving Role of Liquid Biopsy for Lung Cancer

IASLC - ASCO 2023 Highlights

WCLC 2023 Preview: Singapore

LCC in Polish: Overcoming Barriers to Lung Cancer Therapy in Poland

Lung Cancer Considered: Decoding ROS1 Fusions in Lung Cancer

SCLC Transformation in EGFR NSCLC

Updated IASLC - ADAURA

IASLC - Meeting the New JTO CRR Editor in Chief

IASLC - French Language Podcast

IASLC - ELCC 2023 Highlights

IASLC - EGFR Mutant NSCLC Post Osimertinib

IASLC - LCC in Italian: Updates in Resectable NSCLC

IASLC - SCLC 2023 Meeting Preview

IASLC The Great Debate Dr. Einhorn Dr. Simone And Dr. Florez

LCC Targeted Therapy Recap

IASLC - Neoadjuvant

IASLC EGFR AM And PM

IASLC RET NSCLC

IASLC - KRAS G12C

IASLC - LALCA Highlights

IASLC FDA Approval Adjuvant Pembrolizumab For NSCLC

IASLC IPASS Study 2

Lung Cancer In Brazil with Clarissa Maria Cerqueira, Mathias Ticiana Leal And Carlos G. Ferreira

Patient Advocacy Groups with Janet Freeman-Daily, Seamus Cotter & Terri Conneran

Radon with Hina Khan And Laura Mezquita

Radiology - Management of Lung Cancer with Florian Fintelmann and Carole Ridge

FDA Approval: Adagrasib with Sheena Bhalla and Joshua Sabari

Lung Cancer in Israel with Alona Zer, Jair Bar and Nir Peled

ACLC & ESMO Asia 2022 Highlights

Lung Cancer in the Middle East with Nagla Karim, Houssein Abdul Sater, and Abdelrahman Mohamed

MET In NSCLC with Noemi Reguart and Ross Camidge

EMPOWER-Lung 3 with Jordi Remon and Isabel Preeshagul

The POSEIDON Trial With Tejas Patil

Evolution Of Stage III NSCLC with Martin Reck and Paula Antonia Ugalde Figueroa

Climate Change & Lung Cancer, Part 2 with Christine Berg And Roselle De Guzman

Seminal Trial Series: ECOG 1594

Lung Cancer Care In Rural US With Debora Bruno And Gabrielle Rocque

Lung Cancer in China - Mandarin

Lung Cancer in Japan with Misako Nagasaka, Tetsuya Mitsudomi and Takashi Seto

Liquid Biopsy with David Gandara, Charu Aggarwal and Christian Rolfo

Interventional Pulmonary with Rebecca Krochmal and Daniel Sterman

ESMO 2022 Highlights

Pathology with Dara Aisner And Ignacio Wistuba

NACLC 2022 Wrap Up